Cargando…
Cholestatic liver diseases: new targets, new therapies
Cholestatic liver diseases result from gradual destruction of bile ducts, accumulation of bile acids and self-perpetuation of the inflammatory process leading to damage to cholangiocytes and hepatocytes. If left untreated, cholestasis will lead to fibrosis, biliary cirrhosis, and ultimately end-stag...
Autores principales: | Santiago, Priscila, Scheinberg, Andrew R., Levy, Cynthia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109852/ https://www.ncbi.nlm.nih.gov/pubmed/30159035 http://dx.doi.org/10.1177/1756284818787400 |
Ejemplares similares
-
The Management of Cholestatic Liver Diseases: Current Therapies and Emerging New Possibilities
por: Mazzetti, Marta, et al.
Publicado: (2021) -
Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents
por: Hasegawa, Sho, et al.
Publicado: (2021) -
Current and future therapies for inherited cholestatic liver diseases
por: van der Woerd, Wendy L, et al.
Publicado: (2017) -
The Gut-Liver Axis in Cholestatic Liver Diseases
por: Blesl, Andreas, et al.
Publicado: (2021) -
Review: Pathogenesis of cholestatic liver diseases
por: Yokoda, Raquel T, et al.
Publicado: (2020)